Browse by Title

Type here to filter the list

N
New Arterial Risk Factors (eg. Lp(a), CHIP, TMAO, etc.)

Scott J. Cameron, MD, PhD – Cleveland Clinic Foundation ### 1075336###Speaker###Section Head Vascular Medicine###Cleveland Clinic Foundation###
Speaker: Scott J. Cameron, MD, PhD – Cleveland Clinic Foundation
###
Nonthrombotic Iliac Vein Compression Syndrome: Conservative Therapy First/Endovascular Therapy First - Conservative Therapy First Position

Lisa Bennett, MD (she/her/hers) – Denver Health & Hospital Authority ### 1926410###Speaker###Chief of Vascular Surgery###Denver Health & Hospital Authority###
Speaker: Lisa Bennett, MD (she/her/hers) – Denver Health & Hospital Authority
### she/her/hers
Nonthrombotic Iliac Vein Compression Syndrome: Conservative Therapy First/Endovascular Therapy First - Endovascular Therapy First Position

Olusegun Osinbowale, MD (he/him/his) – Henry Ford Health System ### 1800600###Speaker###Senior Staff ###Henry Ford Health System###
Speaker: Olusegun Osinbowale, MD (he/him/his) – Henry Ford Health System
### he/him/his
Novel MRA Approaches: Use of Non-contrast MRA in Vascular Diseases

Sandeep Hedgire, MD – Massachusetts General Hospital ### 1926412###Speaker###Chief, Cardiovascular Imaging ###Massachusetts General Hospital ###
Speaker: Sandeep Hedgire, MD – Massachusetts General Hospital
###
Novel Thrombotic Mechanisms: Monoclonal Gammopathy of Thrombotic / Thrombocytopenic Significance

Anand Padmanabhan, MD PHD – Mayo Clinic ### 1917373###Speaker###Associate Professor###Mayo Clinic###
Speaker: Anand Padmanabhan, MD PHD – Mayo Clinic
###